Technical

Technology Platform

Products

Intellectual property

Jiuzhitang Maker received fund support from Daxing District Program for Better Development of the Healthcare Industry.

Jiuzhitang Maker received fund support from Daxing District Program for Better Development of the Healthcare Industry.

Previous

Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA emergency IND approval for using its bone marrow-derived mesenchymal stem cells to treat severe COVID-19 cases.

Jiuzhitang Maker was included in a government project translating results from COVID-19 prevention and treatment work.

Next